Caspofungin also has in vitro activity against Candida species (Candida albicans [ N = # ], Candida dubliniensis [ N = # ], Candida glabrata [ N = # ], Candida guilliermondii [ N = # ], Candida kefyr [ N = # ], Candida krusei [ N = # ], Candida lipolytica [ N = # ], Candida lusitaniae [ N = # ], Candida parapsilosis [ N = # ], Candida rugosa [ N = # ], and Candida tropicalis [ N = # ]), including isolates with multiple resistance transport mutations and those with acquired or intrinsic resistance to fluconazole, amphotericin B, and #-flucytosine
Kaspofungiini tehoaa in vitro myös Candida-lajeihin (Candida albicans [ N = # ], Candida dubliniensis [ N = # ], Candida glabrata [ N = # ], Candida guilliermondii [ N = # ], Candida kefyr [ N = # ], Candida krusei [ N = # ], Candida lipolytica [ N = # ], Candida lusitaniae [ N = # ] Candida parapsilosis [ N = # ], Candida rugosa [ N = # ] ja Candida tropicalis [ N = # ]), mukaan lukien moniresistentit siirtomutaatioisolaatit ja ne, joilla on hankinnainen tai sisäsyntyinen resistenssi flukonatsolia, amfoterisiini B: tä ja #-flusytosiinia vastaanEMEA0.3 EMEA0.3